BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24176672)

  • 1. Circulating tumor cells in Hodgkin's lymphoma - a review of the spread of HL tumor cells or their putative precursors by lymphatic and hematogenous means, and their prognostic significance.
    Gharbaran R; Park J; Kim C; Goy A; Suh KS
    Crit Rev Oncol Hematol; 2014 Mar; 89(3):404-17. PubMed ID: 24176672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
    Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
    Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular origin and clonality of classic Hodgkin's lymphoma: immunophenotypic and molecular studies.
    Stein H; Hummel M
    Semin Hematol; 1999 Jul; 36(3):233-41. PubMed ID: 10462323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
    Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
    N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hodgkin and Reed/Sternberg cell.
    Küppers R; Hansmann ML
    Int J Biochem Cell Biol; 2005 Mar; 37(3):511-7. PubMed ID: 15618006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and cytochemical studies of circulating Hodgkin's and Reed-Sternberg cells.
    Malfitano A; Cazzola M; Cavalli P; Gobbi PG; Gorini M; Ascari E; Perugini S
    Basic Appl Histochem; 1980; 24(2):101-7. PubMed ID: 6158308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
    Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
    Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hodgkin and Sternberg-Reed cells--cell origin, cell marker, cell function].
    Plat M; Kunze KD; Frank KH; Fleischer J; Koslowski R; Plat U
    Arch Geschwulstforsch; 1988; 58(6):419-30. PubMed ID: 3066301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-needle aspiration cytology of metastatic nasopharyngeal carcinoma in cervical lymph nodes: comparison with metastatic squamous-cell carcinoma, and Hodgkin's and non-Hodgkin's lymphoma.
    Kollur SM; El Hag IA
    Diagn Cytopathol; 2003 Jan; 28(1):18-22. PubMed ID: 12508177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's lymphoma: molecular targets and novel treatment strategies.
    Yazbeck V; Georgakis GV; Wedgwood A; Younes A
    Future Oncol; 2006 Aug; 2(4):533-51. PubMed ID: 16922620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.
    Yurchenko M; Sidorenko SP
    Exp Oncol; 2010 Dec; 32(4):214-23. PubMed ID: 21270747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma.
    Adams H; Fritzsche FR; Dirnhofer S; Kristiansen G; Tzankov A
    Expert Opin Ther Targets; 2010 Jun; 14(6):577-84. PubMed ID: 20415600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
    Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
    J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin lymphoma: pathology, pathogenesis, and a plethora of potential prognostic predictors.
    King RL; Howard MT; Bagg A
    Adv Anat Pathol; 2014 Jan; 21(1):12-25. PubMed ID: 24316907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
    Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
    Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathobiology of classical Hodgkin lymphoma.
    Tzankov A; Dirnhofer S
    Pathobiology; 2006; 73(3):107-25. PubMed ID: 17085956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.